The company continue to develop this program for the WHO markets, thereby providing coverage and protection for more infants globally in time to come
The cash and debt free consideration value is €370 million.
Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
Centre and states need to work in tandem and in a collaborative spirit as was done during the previous surges for COVID-19 prevention and management
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
Miravo to remain a Canadian controlled and operated company following closing of the transaction
The balance of AUD 94 Million was a deferred consideration backed by a secured interest-bearing instrument
Subscribe To Our Newsletter & Stay Updated
